Authors' credentials and e-mail addresses are not used for other purposes.
The submitted articles should be previously unpublished and should not be under consideration by any other journal.
If the whole or a part of the submitted articles are presented in any congress, this should be noted in the submitted article.
The journal's Editorial Board handles all appeal and complaint cases within the scope of Committee on Publication Ethics (COPE) guidelines. In such cases, authors should contact the editorial office directly regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process for all appeals and complaints.
The editorial and publication processes of the journal are shaped following the guidelines of the International Council of Medical Journal Editors (ICMJE).
The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (DOAJ).
Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
An approval of research protocols by the Ethics Committee following international agreements (World Medical Association Declaration of Helsinki "Ethical Principles for Medical Research Involving Human Subjects" ) is required for experimental, clinical, and drug studies and some case reports.
For all research that requires ethics committee permission ethics committee approval should be obtained, this approval should be stated and documented in the article.
In studies that require ethics committee permission, information about the permission (name of the committee, date, and number) can be found in the method section, as well as on one of the first/last pages of the article; In case reports, information about signing the informed consent/consent form should be included in the article.
• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures they may undergo.
• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.
• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.
• It is the authors' responsibility to protect the patients' anonymity carefully. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.
All submissions are screened by a similarity detection software (iThenticate), and the limitation without similarity is 20%.
The Endourology Bulletin holds national and international copyright for all published content. If a submission is rejected for publication, the copyright is automatically returned to the authors.
Authors do not receive any royalties or financial compensation for articles published in the journal. Additionally, no fees are charged for manuscript submission, peer review, or publication.
The copyright terms for each published article are explicitly stated in the publication files and on the journal’s website. Manuscripts submitted to the Endourology Bulletin must be accompanied by the "Copyright Agreement&Acknowledgment of Authorship Form".
Authors are responsible for ensuring that their work does not infringe upon any existing copyrights. If content such as figures, tables, or other materials—whether in print or electronic format—is borrowed from other sources, authors must obtain appropriate permissions from the copyright holders. Legal, financial, and criminal liabilities arising from copyright violations rest solely with the authors.
All content published in the Endourology Bulletin is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license. This license grants the right to share, copy, redistribute, remix, adapt, and build upon the material for any purpose except commercial use, provided that proper attribution is given and the derivative work is distributed under the same license.
Scope of License:
The CC BY-NC-SA 4.0 license grants users the freedom to:
Share – Copy and redistribute the material in any medium or format.
Adapt – Remix, transform, and build upon the material.
Conditions:
Attribution must be provided to the original authors.
Adaptations must be licensed under the same terms.
The work cannot be used for commercial purposes.
Author Responsibilities
Copyright Agreement: Authors must review and accept the terms outlined in the "Copyright Agreement&Acknowledgment of Authorship Form" before submitting their manuscript. A signed copy of this agreement must be uploaded along with the submission.
Originality of Work: Authors confirm that the submitted manuscript is their original creation and does not involve plagiarism. Any third-party materials used must be properly cited in accordance with the CC BY-NC-SA 4.0 license.
Author Accountability: Each author has individually contributed to the work and is fully responsible for its content. Authors also confirm compliance with citation standards and licensing terms.
Approval of Submission: All authors must review and approve the final version of the manuscript before submission.
Prior Publication: Authors affirm that the manuscript has not been published elsewhere and is not under consideration for publication in another journal simultaneously.
Intellectual Property Compliance: Authors are responsible for ensuring that any texts, figures, or documents included in their work do not violate third-party copyrights.
Publication Authorization: Authors grant the Endourology Bulletin permission to publish the manuscript under the CC BY-NC-SA 4.0 license, recognizing the journal as the original publisher. To maintain academic integrity, proper citation must be given, including a DOI link to the publisher’s version of the article.
Third-Party Use: Authors allow third parties to freely use the published article as long as proper attribution is given and the appropriate citation details are included. The license does not restrict the integrity or ownership of the work.
Manuscripts can only be submitted through the journal's online manuscript submission and evaluation system, available at https://dergipark.org.tr/en/pub/endouroloji. Manuscripts submitted via any other medium will not be evaluated.
Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted following the journal's guidelines.
Submissions that do not conform to the journal's guidelines will be returned to the submitting author with technical correction requests.
Corrections may be done without changing the main text.
The editor reserves the right to reject manuscripts that do not comply with the aforementioned requirements.
Authors are required to submit the following:
• Copyright Agreement&Acknowledgement of Authorship Form,
• Informed Consent Form
• ICMJE Disclosure of Interest Form
• Title Page (including Title of Manuscript, Running title, author (s) 's name, title, and institution, corresponding author's contact information, Name of the organization supporting the research)
• Main document (All articles should have an abstract before the main text).
• Figures (Jpeg format)
• Tables (max 6 tables)
Type of Article | Abstract | Text (Word) | References | Table&Figures |
Original Article | 250 | 4000 | 30 | 10 |
Review Article | 250 | 5000 | 100 | 10 |
Case Reports | 300 | 2000 | 20 | 10 |
Original articles should have a structured abstract. (Objective, Material and Methods, Results, Conclusion).
For case reports, the structured abstract is not used. Limit the abstract to 300 words.
References, tables, and citations should not be used in an abstract.
Authors must include relevant keywords (3-5) on the line following the end of the abstract.
The Turkish title, abstracts, and Turkish keywords are not required for the international authors. The editorial office will provide these.
All acronyms and abbreviations used in the manuscript should be defined first, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the definition.
When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in the USA), should be provided in parentheses.
For keywords, please see Medical Subject Headings (MeSH): https://meshb.nlm.nih.gov/MeSHonDemand.
All references, tables, and figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text. The symbols used must be nomenclature used standards.
References
The references used in the article must be written in parenthesis at the end of the sentences.
References should be numbered in the order they appear in the text and placed at the end of the article.
References must contain surnames and initials of all authors, article title, name of the journal, the year, and the fırst and last page numbers.
Articles with 5 or more authors 'et al.' are mixed with the first three authors.
Abbreviations should be according to Index Medicus.
Authors must add the DOI (Digital object identifier) at the end of each reference.
For Examples;
Article in journal: 1. Tasci A, Tugcu V, Ozbay B, Mutlu B, Cicekler O. Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. J Endourol 2009;23:1879-81. https://doi.org/10.1089/end.2008.0596
For Books: 1.Günalp İ: Modern Üroloji. Ankara: Yargıçoğlu matbaası, 1975. Chapters in books: Anderson JL, Muhlestein JB. Extra corporeal ureteric stenting during laparoscopic pyeloplasty. Philadelphia: W.B. Saunders; 2003. p. 288-307
For website; Gaudin S. How moon landing changed technology history [Internet]. Computerworld UK. 2009 [cited 15 June 2014]. Available from: http://www.computerworlduk.com/in-depth/it-business/2387/how-moon-landing-changed-technology-history/
For conference proceeding; Proceedings of the Symposium on Robotics, Mechatronics and Animatronics in the Creative and Entertainment Industries and Arts. SSAISB 2005 Convention. University of Hertfordshire, Hatfield, UK; 2005.
For Thesis; Ercan S. Venöz yetmezlikli hastalarda kalf kası egzersizlerinin venöz fonksiyona ve kas gücüne etkisi. Suleyman Demirel University Faculty of Medicine Sports Medicine Department Thesis. Isparta: Suleyman Demirel University. 2016.
Manuscript Withdrawal & Reject
Withdrawal of the Article: Authors are required to submit a written application addressed to the Editor who has declared their withdrawal request and justification. They must wait for the Editor's response before submitting the manuscript to another journal.
Rejection: The manuscripts which are not accepted to be published are rejected with explanations.
If the manuscript is accepted, the acceptance letter is sent within two weeks, the last version of the manuscript is sent to the author for the last correspondence. The journal owner and the editorial board are authorized to decide which volume of the accepted article will be printed.
Authors may publish their articles on their personal or corporate websites by linking them to the appropriate cite and library rules.
Should you wish to request a change of author (name, author addition), we kindly ask that you submit this to the Editorial Board (publisher/journal address) with a letter signed by all authors before the evaluation process is completed.
For more information about withdrawals and corrections, please see the Retraction and Correction Policy page.